SLC6A3 and hepatocellular carcinoma: Some reports have shown that the expression level of SLC6A3 is significantly higher in gastric carcinoma, hepatocellular carcinoma, and renal cell carcinoma than in control tissues, and that it may be related to increased metastasis and proliferation [30,31,32,33].